A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia (Pathway)

  • Kaplan, Zane (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

HREC Reference Number: 92520
Monash Health Local Reference: RES-23-0000-141X
StatusActive
Effective start/end date29/03/2328/03/28